Asymmetrically Substituted m-Terphenyl Phosphates Inhibit the Transcription Factor STAT5a

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Drug Discovery

Background:

• Signal Transducer and Activator of Transcription 5a (STAT5a) is a key transcription factor implicated in various cellular processes.
• Selective inhibition of STAT5a over its homolog STAT5b is crucial for targeted therapeutic interventions.
• Stafia-1 was previously identified as the first selective STAT5a inhibitor, binding to the SH2 and linker domains.

Purpose of the Study:

• To develop a synthetic strategy for asymmetrically substituted m-terphenyl phosphates.
• To tailor these compounds for more specific interactions with the asymmetric STAT5a binding site.
• To explore structure-activity relationships for novel STAT5a inhibitors.

Main Methods:

• Synthesis of asymmetrically substituted m-terphenyl phosphates.
• Conversion of the most active compound to a phosphatase-stable monofluoromethylene phosphonate.
• Structure-activity relationship analysis of the synthesized compounds.

Main Results:

• A novel synthetic route for asymmetric m-terphenyl phosphates was established.
• The highest-activity compound was successfully converted to a more stable analog.
• Initial structure-activity relationships for selective STAT5a inhibition were elucidated.

Conclusions:

• Asymmetric m-terphenyl phosphates offer a promising scaffold for developing selective STAT5a inhibitors.
• The synthetic methodology enables fine-tuning of inhibitors for specific binding site interactions.
• This work provides a foundation for further optimization of STAT5a-targeted therapeutics.